| Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African Children (NCT05354258) | London School of Hygiene and Tropical Medicine | 2022-06-16 |
| Safety, Tolerability, and Immunogenicity Study of Sm-p80 + GLA-SE (SchistoShield(R)) Vaccine in Healthy Adults (NCT05292391) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-05-23 |
| Retrospective Study of Clinical Practice and Management of Imported Schistosomiasis in France (NCT04810741) | Assistance Publique - Hôpitaux de Paris | 2021-12-21 |
| Repeated Controlled Human Schistosoma Mansoni Infection (NCT05085470) | Leiden University Medical Center | 2021-10-29 |
| Praziquantel in Children Under Age 4 (NCT03640377) | Rhode Island Hospital | 2021-02-01 |
| Selexipag for the Treatment of Schistosomiasis-Associated Pulmonary Arterial Hypertension (NCT04589390) | University of Sao Paulo General Hospital | 2020-10-15 |
| Monitoring Schistosome Hybrids Under Under Praziquantel Pressure (NCT04635553) | Institut de Recherche pour le Developpement | 2020-08-11 |
| Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults (NCT03910972) | Baylor College of Medicine | 2019-10-07 |
| Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study (NCT04115072) | Regionshospital Nordjylland | 2019-09-03 |
| L-PZQ ODT in Schistosoma Infected Children (NCT03845140) | Merck KGaA, Darmstadt, Germany | 2019-09-02 |
| Anti-Schistosomiasis Vaccine: Sm14 Phase 2b-Sn in School Children (NCT03799510) | Oswaldo Cruz Foundation | 2018-12-13 |
| Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST) (NCT02868385) | Leiden University Medical Center | 2018-10-01 |
| A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel)(R) With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed Adults (NCT03110757) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-05-20 |
| Seropositivity and Adverse Birth Events in Migrants From Bilharzia-endemic Areas (NCT03158298) | Jena University Hospital | 2017-06-01 |
| Schistosomiasis in Senegal (NCT03187366) | University of Notre Dame | 2017-01-02 |
| Study of Safety and Immune Response of the Sm14 Vaccine in Adults of Endemic Regions (NCT03041766) | Oswaldo Cruz Foundation | 2016-12-06 |
| Single-sex Controlled Human Schistosomiasis Infection: Safety and Dose Finding (NCT02755324) | Leiden University | 2016-10-27 |
| An Open Label Dose Finding Safety and Efficacy in Children and Infants Infected With Schistosomiasis (S.Mansoni) (NCT02806232) | Merck KGaA, Darmstadt, Germany | 2016-06-12 |
| Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With Schistosomiasis (NCT02734186) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-04-06 |
| Childhood Schistosomiasis: a Novel Strategy Extending the Benefits/Reach of Antihelminthic Treatment (NCT02495909) | University of Edinburgh | 2016-02-01 |
| A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy Adults (NCT02337855) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-02-04 |
| Detection of Schistosomiasis CAA in Travellers After High-risk Water Contact (NCT02194712) | Meta Roestenberg | 2015-01-01 |
| Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders (NCT02105714) | Swiss Tropical & Public Health Institute | 2014-07-01 |
| Arachidonic Acid Treatment Against Schistosomiasis Infection in Children (NCT02144389) | dsm-firmenich Switzerland AG | 2013-01-01 |
| Evaluation of Strategies for Improved Uptake of Preventive Treatment for Intestinal Schistosomiasis (NCT01869465) | Makerere University | 2012-10-01 |
| Health Benefits of Repeated Treatment in Pediatric Schistosomiasis (NCT01424410) | University of Edinburgh | 2012-02-01 |
| Praziquantel-Pharmacokinetic Study (NCT01288872) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-01-01 |
| Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern Senegal (NCT01553552) | Biomedical Research Center EPLS | 2011-10-01 |
| Study to Evaluate the Safety of the Vaccine Prepared sm14 Against Schistosomiasis (NCT01154049) | Oswaldo Cruz Foundation | 2011-03-01 |
| Prevalence of Chronic Kidney Disease (CKD) and Risk Factors in Sub-Saharan Africa (NCT03458338) | University Hospital, Basel, Switzerland | 2010-12-08 |
| Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, Ghana (NCT01459146) | Navrongo Health Research Centre, Ghana | 2010-12-01 |
| Correlating Protection Against Malaria With Serum Profiles Against Plasmodium Falciparum Antigen Repertoires (NCT01214876) | Radboud University Medical Center | 2010-08-01 |
| Antioxidant Supplements in the Reversal of Schistosomal Peri-portal Fibrosis (NCT01260012) | Addis Ababa University | 2010-01-01 |
| Schistosoma Haematobium Infections and Praziquantel (NCT01558336) | University of Khartoum | 2008-08-01 |
| S. Japonicum and Pregnancy Outcomes (NCT00486863) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-08-01 |
| Schistosomiasis in Women of Reproductive Age in Burkina Faso: Implications for Control (NCT00463632) | DBL -Institute for Health Research and Development | 2007-01-01 |
| Schistosomiasis in Formal and Non-Formal Schools in Uganda: Implications for Control Programmes (NCT00463593) | DBL -Institute for Health Research and Development | 2006-12-01 |
| Women and Children as the Focus for Control of Schistosomiasis Infections in the Irrigations Area of Burkina Faso (NCT00463528) | DBL -Institute for Health Research and Development | 2006-12-01 |
| Using Community-Based Volunteers to Reach Non-Enrolled School Aged Children Through Community-Directed Treatment of Schistosomiasis in School-Aged Children in Rural Northern Ghana (NCT00463931) | DBL -Institute for Health Research and Development | 2006-09-01 |
| Iron Supplementation in Schistosomiasis and Soil Transmitted Helminths Control Programmes in Zambia (NCT00276224) | DBL -Institute for Health Research and Development | 2005-09-01 |
| Clinical Trial of Bilhvax,a Vaccine Candidate Against Schistosomiasis (NCT01512277) | University Hospital, Lille | 1998-09-01 |